Back to top
more

Cronos Group (CRON)

(Real Time Quote from BATS)

$2.42 USD

2.42
128,013

+0.04 (1.68%)

Updated Jul 12, 2024 10:30 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth B Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (151 out of 250)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Sweta Killa headshot

ETFs and Stocks to Tap the Marijuana Boom

by Sweta Killa

First it was bitcoin that made investors go on a mad rush, and today, it's marijuana. Now that legalization is steadily gaining traction across the U.S., more investors than ever before are looking for ways to cash in.

Sanghamitra Saha headshot

4 Reasons Why Marijuana Stocks & ETFs Could Be on a High in 2019

by Sanghamitra Saha

Marijuana stocks and related ETFs caught investors' attention last year, courtesy of its mysterious rally in mid-2018 on Canada's legalization of recreational marijuana in October. Let's take a look at whether the space will be able to maintain its rally in 2019.

Sweta Killa headshot

Why Marijuana ETFs are on a High in 2019

by Sweta Killa

After being beaten down in the final quarter of 2018, pot stocks staged a nice comeback at the start of this year on the renewed appeal for riskier assets. Here's why ETFs are riding high this year.

4 Best Marijuana Stocks to Play the Green Rush

by Zacks Equity Research

Whether its eating a gooey, chocolatey brownie or taking a few hits off a freshly rolled joint, it???s common knowledge that a lot of people like to get high. Many investors, however, have yet to "light up." What are the best marijuana stocks out there right now?

Tracey Ryniec headshot

Pot Stocks: Who Has the Best Earnings Chart?

by Tracey Ryniec

Pot stocks are entering the investing mainstream but do they have what it takes to compete against mature industries?

Sweta Killa headshot

Will Q4 Results Continue to Fuel Momentum in Marijuana ETF?

by Sweta Killa

Investors are keenly watching whether legalization is living up to the hype in the quarterly results of the cannabis stocks.

Sanghamitra Saha headshot

Buy the Dip in Marijuana Stocks & ETF?

by Sanghamitra Saha

Marijuana stocks and ETF slumped on Feb 6. Is this the time to buy?

Sweta Killa headshot

Marijuana ETF Joins Billion Dollar Club

by Sweta Killa

Marijuana ETF has now accumulated billion dollars in AUM since its inception in less than 14 months.

Sanghamitra Saha headshot

Pot Stocks are on a High: Play These Marijuana ETFs

by Sanghamitra Saha

As marijuana stocks soar into the new year, which ETFs should investors consider?

The Zacks Analyst Blog Highlights: Cronos, Altria, Canopy and Tilray

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Cronos, Altria, Canopy and Tilray

Ryan McQueeney headshot

Here's Why Cannabis Stocks (ACB, CRON) Are Gaining Today

by Ryan McQueeney

Shares of several notable cannabis stocks, including Aurora Cannabis (ACB) and Cronos Group (CRON), were up more than 10% through early afternoon trading hours Monday.

Sweta Killa headshot

5 Top Performing Stocks of Marijuana ETF

by Sweta Killa

We have highlighted five best-performing stocks of the top ETF of January.

Altria (MO) Q4 Earnings Beat, Strong Pricing Aids Revenues

by Zacks Equity Research

Altria's (MO) Q4 performance gains on improved pricing. However, shipment volume in the smokeable unit continued to decline.

Cronos Group (CRON) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

Cronos Group (CRON) closed the most recent trading day at $18.15, moving -1.79% from the previous trading session.

Sanghamitra Saha headshot

What Makes Marijuana ETF the Best Performer in January?

by Sanghamitra Saha

These are the factors that led marijuana ETF to see a strong start to 2019.

Altria's (MO) Q4 Earnings to Gain From Prudent Pricing & RRPs

by Zacks Equity Research

Altria (MO) gains from higher pricing as well as rising popularity of low risk tobacco products. However, declining cigarette sales volumes is a worry.

Cronos Group (CRON) Catches Eye: Stock Jumps 9.1%

by Zacks Equity Research

Cronos Group (CRON) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

Cronos Group (CRON) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Cronos Group (CRON) closed the most recent trading day at $13.66, moving +1.79% from the previous trading session.

Zacks Investment Ideas feature highlights: Tilray, Canopy and Cronos

by Zacks Equity Research

Zacks Investment Ideas feature highlights: Tilray, Canopy and Cronos

Sweta Killa headshot

Why Marijuana ETF is on a High in 2019

by Sweta Killa

After being beaten down in the final quarter of 2018, pot stocks staged a nice comeback this year on the renewed appeal for riskier assets.

David Borun headshot

Tilray's Tuesday Slide Due to IPO Lockup Expiration

by David Borun

Tilray's biggest shareholder resolves to stay long for the foreseeable future

Tilray Shares Rally as Investor Plans Not to Sell Shares

by Zacks Equity Research

Tilray (TLRY) gains after Privateer Holdings decides not to sell shares in the first half of 2019.

Can Altria's Expansion in RRPs & Cannabis Enable a Revival?

by Zacks Equity Research

Altria (MO) strives to expand in RRPs and Cannabis to stay afloat, amid receding cigarette sales.

Cronos Group (CRON) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Cronos Group (CRON) closed at $12.36 in the latest trading session, marking a -0.32% move from the prior day.

Ryan McQueeney headshot

The Top Cannabis Investing Storylines to Watch in 2019

by Ryan McQueeney

Ryan McQueeney chats with Zacks Stock Strategist Dave Borun about the top cannabis investing storylines to watch in 2019, including new legal issues, the most exciting areas for growth, and a new model portfolio that will feature some of the industry's top stocks.